Growth Hormone
FDA Approved
Approved (Egrifta)
Tesamorelin
Egrifta
FDA-approved for HIV lipodystrophy. Reduces visceral adipose tissue by stimulating natural GH production.
Quick Facts
Amino Acids
44
Route
subcutaneous
Evidence
FDA Approved
FDA Status
Approved (Egrifta)
Mechanism of Action
GHRH analog -- specifically approved to reduce excess abdominal fat in HIV-associated lipodystrophy